Efficacy of individualized homoeopathic treatment of hypertension: double blind, randomized placebo controlled clinical trial

ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 68 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients suffering from stage I hypertension (as defined by JNC8 classification, i.e., systolic 140-159 mm Hg or Diastolic 90-99 mm Hg)
•2. Age 18-65 years
•3. Both sexes
•4. New hypertensive patients (those who are accidentally discovered as hypertensive while complaining of some other functional disorders)
•5. Patients who have not taken any anti-hypertensive medicine in last week

•1. Patients who are too sick for consultation
•2. Unwilling to take part and not giving consent to join the study
•3. Unable to read patient information sheet
•4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness affecting quality of life or any organ failure
•5. Pregnancy and lactation
•6. Substance abuse and/or dependence
•7. Self-reported immune-compromised state
•8. Undergoing homoeopathic treatment for any chronic disease within last 6 months

发起方

ational Institute of Homoeopathy Ministry of AYUSH Govt of India